Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

Marie Skłodowska-Curie Action · Running

i-GREENPHARM AI and machine learning assisted development of greener formulations and pharmaceutical processes based on amorphous solid dispersions

Coordinator
Anfarm Hellas Ap Nikolaou Pharmaceutical Industry SA, Greece
Runs
1 January 2025 to 31 December 2028
Status
Running
EU funding
€773k
Total cost
—
Partners
10 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101182850

What the project is doing

In the project's own words, from its summary on CORDIS.

This proposal is bringing together R&I related staff by a complementary set of participating organisations that will use multidisciplinary technological approaches to provide a proof-of concept framework for designing and introducing greener practices in pharmaceuticals. Knowledge will be transferred around the core technical activity that will be the introduction of HME as a novel production method, based on AI-ML tools and supported by environmental assessment for greener pharmaceuticals.

Topics

Who is involved

OrganisationCityCountryRole
Anfarm Hellas Ap Nikolaou Pharmaceutical Industry SAKifissiaGreeceCoordinator
Sidroco Holdings LimitedNicosiaCyprusParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Atlantic Technological UniversityLetterkennyIrelandParticipant
University of LimerickLimerickIrelandParticipant
Vodena Doo KragujevacKragujevacSerbiaParticipant
Chulalongkorn UniversityBangkokTHAssociatedpartner
Thailand Institute of Nuclear Technology (Public Organization)Saimoon, Ongkarak, Nakorn NayokTHAssociatedpartner
Queen Mary University of LondonLondonUnited KingdomAssociatedpartner
University College LondonLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI